Fri, August 31, 2012
Thu, August 30, 2012
Wed, August 29, 2012
Tue, August 28, 2012
Mon, August 27, 2012
Sun, August 26, 2012
Sat, August 25, 2012
Fri, August 24, 2012
Thu, August 23, 2012
Wed, August 22, 2012
[ Wed, Aug 22nd 2012 ] - Market Wire
Inergetics Shareholder Update
Tue, August 21, 2012
Mon, August 20, 2012
[ Mon, Aug 20th 2012 ] - Market Wire
Watson Launches Generic Xopenex
Sat, August 18, 2012
Fri, August 17, 2012
Thu, August 16, 2012
Wed, August 15, 2012
Tue, August 14, 2012

Branham Law, LLP Announces an Investigation of Chelsea Therapeutics International, Ltd. for Possible Securities Law Violations


//health-fitness.news-articles.net/content/2012/ .. -ltd-for-possible-securities-law-violations.html
Published in Health and Fitness on Friday, August 24th 2012 at 13:34 GMT by Market Wire   Print publication without navigation


DALLAS--([ ])--[ Branham Law, LLP ] announces an investigation has been launched into the actions of the officers and directors of [ Chelsea Therapeutics International, Ltd. ] (Nasdaq: CHTP) (aChelseaa or the aCompanya) for possible violations of securities and shareholder protection laws.

If you purchased shares of Chelsea between November 3, 2008 and March 28, 2012 or have relevant information regarding this suit, you are urged to contact attorney [ Trey Branham ] at [ tbranham@branham-law.com ] or toll free at (855) 722-5910.

The investigation focuses on whether the Company and its executives violated federal securities laws by failing to disclose that: (1) Chelseaas Northera (droxidopa) product, an orally-active synthetic precursor of norepinephrine being developed for the treatment of symptomatic neurogenic orthostatic hypotension, would not receive approval from the U.S. Food and Drug Administration; and (2) the Companyas numerous statements regarding the safety and efficacy of the product, as well as reportedly positive results from Northeraas clinical trials, were materially false and misleading.

Branham Law, LLP has significant experience in shareholder representation nationwide.


Publication Contributing Sources